ScholarIQanswers from OpenAlex

A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging

PaperCitations, authors & open-access status

A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging have?

ScholarIQcitation count

A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging has 288 citations in the OpenAlex counts ScholarIQ stores.

When was A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging published?

ScholarIQyear

A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging has 2017 year in the ScholarIQ index.

What is the open-access status of A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging?

ScholarIQoa status

A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging has closed oa status in the ScholarIQ index.

What is the DOI of A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging?

ScholarIQdoi

The DOI for A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging is on the source record.

What is the PMID of A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging?

ScholarIQpmid

The PMID for A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging is on the source record.

What is the OpenAlex record for A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging?

ScholarIQopenalex

The OpenAlex for A sestrin-dependent Erk–Jnk–p38 MAPK activation complex inhibits immunity during aging is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial